{
  "id": "R46341",
  "type": "CRS Report",
  "typeId": "R",
  "number": "R46341",
  "active": true,
  "source": "CRSReports.Congress.gov, EveryCRSReport.com",
  "versions": [
    {
      "summary": null,
      "typeId": "R",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46341",
      "source": "CRSReports.Congress.gov",
      "type": "CRS Report",
      "retrieved": "2021-01-22T04:03:53.725873",
      "source_dir": "crsreports.congress.gov",
      "id": "R46341_12_2020-12-17",
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46341/12",
          "sha1": "c27a17f322b9d54e71bd7cfb1acb327d804976ad",
          "filename": "files/2020-12-17_R46341_c27a17f322b9d54e71bd7cfb1acb327d804976ad.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2020-12-17_R46341_c27a17f322b9d54e71bd7cfb1acb327d804976ad.html"
        }
      ],
      "active": true,
      "title": "Federal Research and Development (R&D) Funding: FY2021",
      "date": "2020-12-17"
    },
    {
      "summary": null,
      "typeId": "R",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46341",
      "source": "CRSReports.Congress.gov",
      "type": "CRS Report",
      "retrieved": "2021-01-22T04:03:53.724762",
      "source_dir": "crsreports.congress.gov",
      "id": "R46341_10_2020-11-30",
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46341/10",
          "sha1": "ce876b0f17d7ff21937c8ffde141cbbf36af2c32",
          "filename": "files/2020-11-30_R46341_ce876b0f17d7ff21937c8ffde141cbbf36af2c32.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2020-11-30_R46341_ce876b0f17d7ff21937c8ffde141cbbf36af2c32.html"
        }
      ],
      "active": true,
      "title": "Federal Research and Development (R&D) Funding: FY2021",
      "date": "2020-11-30"
    },
    {
      "summary": null,
      "typeId": "R",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=R46341",
      "source": "CRSReports.Congress.gov",
      "type": "CRS Report",
      "retrieved": "2021-01-22T04:03:53.721558",
      "source_dir": "crsreports.congress.gov",
      "id": "R46341_5_2020-09-02",
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/R/R46341/5",
          "sha1": "75fde9ee10ca7c7da9ecea9680fbd4c2a78c78da",
          "filename": "files/2020-09-02_R46341_75fde9ee10ca7c7da9ecea9680fbd4c2a78c78da.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2020-09-02_R46341_75fde9ee10ca7c7da9ecea9680fbd4c2a78c78da.html"
        }
      ],
      "active": true,
      "title": "Federal Research and Development (R&D) Funding: FY2021",
      "date": "2020-09-02"
    },
    {
      "source": "EveryCRSReport.com",
      "id": 623712,
      "date": "2020-04-30",
      "retrieved": "2020-05-19T13:57:28.244680",
      "title": "Federal Research and Development (R&D) Funding: FY2021",
      "summary": "President Trump\u2019s budget request for FY2021 includes approximately $142.2 billion for research and development (R&D) for FY2021, $13.8 billion (8.8%) below the FY2020 enacted level of $156.0 billion. In constant FY2020 dollars, the President\u2019s FY2021 R&D request would result in a decrease of $16.6 billion (10.6%) from the FY2020 level.\nFederal Research and Development\nFunding, FY2019-FY2021\nIn billions of dollars\n/\nSource: CRS analysis of data from OMB, Analytical Perspectives, Budget of the United States Government, Fiscal Year 2021, Research and Development, February 10, 2020.\nIn 2017, the Office of Management and Budget (OMB) adopted a change to the definition of development, applying a more narrow treatment that it describes as \u201cexperimental development.\u201d This change was intended to harmonize the reporting of U.S. R&D funding data with the approach used by other nations. The new definition is used in this report.\nFunding for R&D is concentrated in a few departments and agencies. In FY2020, five federal agencies received 93.2% of total federal R&D funding, with the Department of Defense (DOD, 41.4%) and the Department of Health and Human Services (HHS, 26.2%) combined accounting for more than two-thirds of all federal R&D funding. In the FY2021 request, the top five R&D agencies would account for 93.8%, with DOD accounting for 42.1% and HHS for 26.6%.\nUnder the President\u2019s FY2021 budget request, nearly all federal agencies would see their R&D funding decline relative to FY2020. The only exception is the Department of Veterans Affairs, which would increase by $38 million (2.9%) in FY2021 to $1.351 billion. The largest dollar reductions in R&D funding would be made to the DOD (down $4.713 billion), the Department of Energy (down $3.168 billion), and HHS (down $2.843 billion). The largest percentage declines in R&D funding would be at the Department of Transportation (down 47.6%), the Environmental Protection Agency (down 35.4%), and Department of the Interior (down 25.5%)\nThe President\u2019s FY2021 budget request would reduce funding for basic research by $2.822 billion (6.5%), applied research by $5.125 billion (11.7%), development by $3.466 billion (5.5%), and facilities and equipment by $2.375 billion (39.6%).\nSeveral multiagency R&D initiatives continue under the President\u2019s FY2021 budget. Some activities supporting these initiatives are discussed in agency budget justifications and are reported in the agency analyses in this report. However, comprehensive aggregate budget information on these initiatives will likely not be available until budget supplements for each are released later in the year.\nThe request represents the President\u2019s R&D priorities. Congress may opt to agree with none, part, or all of the request, and it may express different priorities through the appropriations process. In recent years, Congress has completed the annual appropriations process after the start of the fiscal year. Completing the process after the start of the fiscal year and the accompanying use of continuing resolutions can affect agencies\u2019 execution of their R&D budgets, including the delay or cancellation of planned R&D activities and the acquisition of R&D-related equipment.\nIt is not yet clear how the national response to the Coronavirus Disease 2019 (COVID-19) pandemic will affect Administration and congressional priorities for FY2021 R&D funding, or the congressional authorization and appropriations processes for enacting that funding.",
      "type": "CRS Report",
      "typeId": "REPORTS",
      "active": true,
      "formats": [
        {
          "format": "HTML",
          "encoding": "utf-8",
          "url": "https://www.crs.gov/Reports/R46341",
          "sha1": "b406ec693f47f60556dd19f9b051bfc70c882a02",
          "filename": "files/20200430_R46341_b406ec693f47f60556dd19f9b051bfc70c882a02.html",
          "images": {
            "/products/Getimages/?directory=R/html/R46341_files&id=/1.png": "files/20200430_R46341_images_08b74fcdfa03a990b778efbcd8058950b8a7c395.png",
            "/products/Getimages/?directory=R/html/R46341_files&id=/0.png": "files/20200430_R46341_images_efc4c61766c58903005f99321037e2b5ec1a6b93.png"
          }
        },
        {
          "format": "PDF",
          "encoding": null,
          "url": "https://www.crs.gov/Reports/pdf/R46341",
          "sha1": "388c433767b0c237f9376a42751c92337d815d67",
          "filename": "files/20200430_R46341_388c433767b0c237f9376a42751c92337d815d67.pdf",
          "images": {}
        }
      ],
      "topics": []
    }
  ],
  "topics": []
}